Prognostic Determinants Associated with Efficacy of Adenoviral p53 Gene Therapy in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck

被引：0
|
作者：
Nemunaitis, John [1 ]
Bier-Laning, Carol [2 ]
Clayman, Gary L. [3 ]
Van Echo, David [4 ]
Guertin, L. [5 ]
Hamm, J. [6 ]
Dreicer, Robert [7 ]
Yoo, George H. [8 ]
Minn, H. [9 ]
Bekradda, M. [10 ]
Sutherland, W. [10 ]
Menander, Kerstin B. [11 ]
Sobol, Robert E. [11 ]
Goodwin, Jerry [12 ]
机构：
[1] Mary Crowley Med Res Ctr, Dallas, TX USA
[2] Loyola Univ, Chicago, IL 60611 USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
[5] CHUM, Montreal, PQ, Canada
[6] Univ Louisville, Louisville, KY 40292 USA
[7] Cleveland Clin, Cleveland, OH 44106 USA
[8] Wayne State Univ, Detroit, MI USA
[9] Turku Univ, Cent Hosp, Turku, Finland
[10] CAC, Le Kremlin Bicetre, Le Kremlin, France
[11] Introgen Therapeut, Houston, TX USA
[12] Univ Miami, Sylvester Canc Ctr, Miami, FL USA
来源：
MOLECULAR THERAPY | 2006年 / 13卷
关键词：
D O I：
10.1016/j.ymthe.2006.08.1034
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
943
引用
收藏
页码：S364 / S364
页数：1
相关论文
共 50 条
  • [1] Analysis of Adenoviral p53 Gene Therapy Clinical Trials in Recurrent Head and Neck Squamous Cell Carcinoma
    Sobol, Robert E.
    Menander, Kerstin B.
    Chada, Sunil
    Wiederhold, Dora
    Sellman, Beatha
    Talbott, Max
    Nemunaitis, John J.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [2] Adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines
    Higuchi, Y
    Asaumi, J
    Murakami, J
    Wakasa, T
    Inoue, T
    Kuroda, M
    Shibuya, K
    Shigehara, H
    Kawasaki, S
    Fuku, K
    Kishi, K
    Hiraki, Y
    ONCOLOGY REPORTS, 2002, 9 (06) : 1233 - 1236
  • [3] Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and Neck
    Nemunaitis, John
    Clayman, Gary
    Agarwala, Sanjiv S.
    Hrushesky, William
    Wells, James R.
    Moore, Charles
    Hamm, John
    Yoo, George
    Baselga, Jose
    Murphy, Barbara A.
    Menander, Kerstin A.
    Licato, Laura L.
    Chada, Sunil
    Gibbons, Robert D.
    Olivier, Magali
    Hainaut, Pierre
    Roth, Jack A.
    Sobol, Robert E.
    Goodwin, W. Jarrard
    CLINICAL CANCER RESEARCH, 2009, 15 (24) : 7719 - 7725
  • [4] Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent, Squamous Cell Carcinoma of the Head and Neck
    Nemunaitis, John
    Clayman, Gary
    Agarwala, Sanjiv
    Hrushesky, William
    Wells, James R.
    Moore, Charles
    Hamm, John
    Yoo, George
    Baselga, Jose
    Murphy, Barbara A.
    Menander, Kerstin A.
    Licato, Laura L.
    Chada, Sunil
    Gibbons, Robert D.
    Olivier, Magali
    Hainaut, Pierre
    Goodwin, W. Jarrard
    Roth, Jack A.
    Sobol, Robert E.
    MOLECULAR THERAPY, 2009, 17 : S139 - S139
  • [5] Biomarkers predict p53 gene therapy efficacy in recurrent squamous cell carcinoma of the head and neck (SCCHN)
    Sobol, Robert
    Nemunaitis, John
    Clayman, Gary
    Roth, Jack
    Olivier, Magali
    Hainaut, Pierre
    Agarwala, Sanjiv
    Hrushesky, William
    Wells, James
    Moore, Charles
    Hamm, John
    Yoo, George
    Baselga, Jose
    Murphy, Barbara
    Menander, Kerstin
    Chada, Sunil
    Licato, Laura
    Gibbons, Robert
    Goodwin, W. Jarrard
    CANCER RESEARCH, 2009, 69
  • [6] Thermoradiotherapy combined with adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines
    Higuchi, Y
    Asaumi, J
    Murakami, J
    Matsuzaki, H
    Wakasa, T
    Inoue, T
    Konoucni, H
    Hisatomi, M
    Yanagi, Y
    Honda, Y
    Shigehara, H
    Kishi, K
    ONCOLOGY REPORTS, 2003, 10 (02) : 415 - 420
  • [7] Adenoviral p53 gene therapy in squamous cell cancer of the head and neck region
    Edelman, J
    Edelman, J
    Nemunaitis, J
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2003, 5 (06) : 611 - 617
  • [8] Tumor response criteria and biomarkers associated with increased survival following adenoviral p53 gene therapy (ADVEXIN) in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN)
    Nemunaitis, J. J.
    Clayman, G.
    Hamm, J.
    Bier-Laning, C.
    Minn, H.
    Van Echo, D.
    Yoo, G.
    Menander, K.
    Sobol, R. E.
    Goodwin, W. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] p53 antibodies as a prognostic indicator in sera of head and neck squamous cell carcinoma patients
    Kwak, JR
    Carey, TE
    Soussi, T
    Bradford, CR
    Werner, JA
    BRITISH JOURNAL OF CANCER, 1998, 77 : 7 - 7
  • [10] Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma
    Clayman, GL
    El-Naggar, AK
    Lippman, SM
    Henderson, YC
    Frederick, M
    Merritt, JA
    Zumstein, LA
    Timmons, TM
    Liu, TJ
    Ginsberg, L
    Roth, JA
    Hong, WK
    Bruso, P
    Goepfert, H
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) : 2221 - 2232
12345